49,668 Axon Enterprise, Inc $AXON Shares Purchased by Brighton Jones LLC

Key Points

• Brighton Jones LLC increased its Axon Enterprise stake by 5,073.3% in the third quarter, purchasing 49,668 shares to hold 50,647 shares worth about $21.4 million.
• Institutional investors and hedge funds own 79.08% of Axon shares, with several other firms also adding to or initiating positions.
• Axon’s shares were down 18.2%; its latest quarter missed analyst estimates for both earnings and revenue, despite revenue growth of 27.8% year over year.

Brighton Jones LLC boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 5,073.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 50,647 shares of the biotechnology company's stock after acquiring an additional 49,668 shares during the quarter. Brighton Jones LLC owned about 0.06% of Axon Enterprise worth $21,399,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Keating Financial Advisory Services Inc. acquired a new stake in shares of Axon Enterprise in the 2nd quarter worth $31,000. Washington Trust Advisors Inc. boosted its holdings in shares of Axon Enterprise by 1,300.0% in the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company's stock valued at $39,000 after acquiring an additional 65 shares in the last quarter. M & L Capital Management Ltd acquired a new position in shares of Axon Enterprise during the third quarter worth about $30,000. Wealth Enhancement Trust Services Inc. acquired a new position in shares of Axon Enterprise during the third quarter worth about $33,000. Finally, Delos Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the second quarter worth about $45,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q3 revenue reached a record $909 million, up 28% year over year, while software and services revenue rose 43%. Axon also reported AI annual recurring revenue above $100 million, signaling continued demand for its software and AI offerings. Axon Q3 results
• Neutral Sentiment: Axon committed an additional $1.2 billion to drone maker Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The move could expand Axon’s Drone as First Responder business, but its scale also raises investment and execution risks. Reuters: Axon invests in Skydio
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of $908.55 million fell short of analyst expectations. Axon’s 2026 revenue forecast was reduced to $3.6 billion from a consensus of about $3.7 billion; its Q4 revenue guidance also came in below estimates. The company cited delays in federal counter-drone projects, while margin pressure added to concerns. Zacks: Q3 miss and outlook
• Negative Sentiment: Several analysts lowered price targets after the results, and Craig Hallum downgraded AXON from Buy to Hold, adding to pressure on investor sentiment. Benzinga: analyst forecast changes
• Negative Sentiment: A class-action lawsuit over Axon’s license-plate surveillance practices is a potential additional legal and reputational overhang. Class-action announcement

Axon Enterprise Stock Down 18.2%

Shares of NASDAQ AXON opened at $313.00 on Friday. The stock has a market capitalization of $25.43 billion, a price-to-earnings ratio of 100.32, a price-to-earnings-growth ratio of 5.95 and a beta of 1.48. Axon Enterprise, Inc has a 52 week low of $307.00 and a 52 week high of $665.07. The firm has a 50-day moving average price of $441.53 and a 200 day moving average price of $475.20. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.95% and a net margin of 7.56%. The company had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. During the same quarter in the previous year, the company posted $1.17 earnings per share. The company's quarterly revenue was up 27.8% compared to the same quarter last year. Equities research analysts anticipate that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on AXON shares. Northland Securities set a $540.00 price objective on shares of Axon Enterprise in a research report on Friday. Barclays boosted their target price on Axon Enterprise from $523.00 to $688.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Weiss Ratings reissued a "hold (c-)" rating on shares of Axon Enterprise in a research note on Tuesday. The Goldman Sachs Group reduced their price target on Axon Enterprise from $715.00 to $675.00 and set a "buy" rating for the company in a report on Monday, September 21st. Finally, Royal Bank Of Canada reduced their target price on Axon Enterprise from $735.00 to $615.00 and set an "outperform" rating for the company in a report on Friday. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $631.35.

Insider Activity at Axon Enterprise

In other news, insider Jeffrey Kunins sold 9,605 shares of the business's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the sale, the insider owned 97,761 shares of the company's stock, valued at $61,266,818.70. The trade was a 8.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the business's stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at $170,590,774.82. This trade represents a 5.35% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 37,397 shares of company stock valued at $21,234,034 in the last 90 days. Insiders own 4.20% of the company's stock.

Axon Enterprise Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.

The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.